Should EMA be stopped

The European Medicines Agency (EMA) plays a crucial role in ensuring the safety and efficacy of medicines in Europe. Stopping the EMA could lead to decreased oversight of pharmaceuticals, potentially compromising public health. However, discussions about its efficiency and processes can lead to improvements rather than complete cessation. Any decision regarding the EMA should carefully consider the implications for patient safety and healthcare systems.